Quantcast
Last updated on April 18, 2014 at 15:44 EDT

Latest Mammotome Stories

2014-04-17 12:29:51

LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:MediPoint: Biopsy Devices - US Analysis and Market Forecastshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_us_analysis_market_forecasts.htmlMediPoint: Biopsy Devices - US Analysis and Market ForecastsSummaryCancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of...

2014-04-17 12:27:05

LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:MediPoint: Biopsy Devices - Current and Future Playershttp://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_current_future_players.htmlMediPoint: Biopsy Devices - Current and Future PlayersSummaryCancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular...

2013-11-19 13:00:32

Breast biopsies can adversely affect short-term quality-of-life, and the effects are more pronounced in younger patients, according to a new study published online in the journal Radiology. More than 500,000 women in the United States have a breast biopsy each year. In the percutaneous method, a physician uses a needle to remove several small samples from the area of interest for pathological analysis. Percutaneous biopsies are associated with fewer complications than the surgical...

2013-11-08 23:20:29

Join DMG Productions as they explore key issues that are impacting our world. (PRWEB) November 08, 2013 DMG Productions is proud to announce an upcoming episode of Innovations with Ed Begley, Jr., airing on Monday, November 18, 2013 at 7:00 a.m. EST via Discovery Channel. In this episode of Innovations, viewers will learn about Knee Creations and their Subchondroplasty® procedure, a minimally invasive surgical intervention that treats bone defects by filling them with a biomimetic...

2013-10-01 23:28:51

DMG Productions explores the latest advancements in health and wellness. Jupiter, FL (PRWEB) October 01, 2013 DMG Productions proudly announces the upcoming airing of Health Heroes on Sunday, October 27, 2013 at 5:30 p.m. EDT on Fox Business. In this episode of Health Heroes, viewers will learn about Mammotome® and their Biopsy System, which allows doctors to achieve diagnostic confidence using a less invasive approach that offers women faster recovery, less scarring and lower costs...

2013-05-21 16:27:15

Award Recognizes Daulton's Corporate Success in Mergers and Acquisitions CINCINNATI, May 21, 2013 /PRNewswire/ -- Tom Daulton, CEO of Mammotome, a division of Devicor Medical Products, has been named Dealmaker of the Year by the Cincinnati chapter of the Association for Corporate Growth (ACG). Daulton, who was nominated by another local top executive who is also a breast cancer survivor, led the purchase of the Mammotome® brand from Ethicon Endo-Surgery in March of 2010. Daulton...

2013-02-21 08:31:10

TORONTO, Feb. 21, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the growing demographic at risk for breast cancer and increasing compliance with screening programs will spur demand for breast biopsies. Additionally, patients and clinicians are showing a growing preference for minimally invasive biopsies over open surgical alternatives. As a result, sales of breast biopsy devices used in these...

2012-12-06 12:28:53

CINCINNATI, Dec. 6, 2012 /PRNewswire/ -- Devicor® Medical Products, Inc. (Devicor) announced today that the U.S. Food and Drug Administration (FDA) has approved Mammotome® revolve(TM), a dual vacuum-assisted biopsy system, for use on patients. Mammotome® revolve(TM) is the next generation biopsy system, leveraging the clinician and pathologist valued benefits of the original Mammotome® system to provide high quality tissue specimens, now enhanced in the new system with...

2012-05-03 13:56:22

Imaging surveillance is an acceptable alternative to surgical excision in patients with benign papilloma, diagnosed at breast core biopsy without cell abnormalities, a new study shows. The study, conducted at the Breast Health Center of California Pacific Medical Center in San Francisco, included 119 papillomas diagnosed at core biopsy without abnormal cells. Imaging follow-up of a minimum of two years without surgical excision was performed on 66 lesions; no cancer was found in this...

2012-04-19 06:27:16

CINCINNATI, April 19, 2012 /PRNewswire/ -- Devicor® Medical Products, Inc. (Devicor), announced today the commercial launch of the Mammotome® elite Biopsy System, the only tetherless single insertion, multiple sample, vacuum-assisted biopsy (VAB) device featuring proprietary TruVac(TM) vacuum technology. Unlike competing devices that rely on automated syringes, elite provides a vacuum that achieves nearly the same suction power of the traditional Mammotome® VAB system, enabling...